In addition to the Summary of Product Characteristics, this leaflet was developed by the marketing authorisation holder to inform you about all delicate issues potentially arising from Leflunomide medac therapy.
Counselling patients on important risks associated with Leflunomide medac therapy and appropriate precautions when using the medicine is required.
You are trying to reach document intended for healthcare professionals only.
Are you a healthcare professional?
medac Pharma LLP
Address
Scion House, Stirling University Innovation Park, Stirling, FK9 4NF, UK